Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Anti-dilutive Securities (Details)

v3.23.1
Net Loss Per Share - Anti-dilutive Securities (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Stock options    
Anti-dilutive securities    
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 1,460,346 1,424,004
Warrants on common stock    
Anti-dilutive securities    
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 4,136,990 367,187
Restricted Stock Units    
Anti-dilutive securities    
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 0 938
Pre-Funded Warrants    
Anti-dilutive securities    
Pre-funded warrants exercised (in shares) 114,007 114,007
Exercise price per share (in dollars per share) $ 0.012 $ 0.012